Cargando…
Idiopathic pulmonary arterial hypertension associated with a novel frameshift mutation in the bone morphogenetic protein receptor II gene and enhanced bone morphogenetic protein signaling: A case report
RATIONALE: Idiopathic pulmonary arterial hypertension (IPAH) is characterized by intense remodeling of small pulmonary arteries. Loss-of-function mutation of bone morphogenetic protein receptor II (BMPR2) gene and exaggerated activation of transforming growth factor (TGF)-β signaling play a critical...
Autores principales: | Choi, Sun Ha, Jung, Youn-Kwan, Jang, Ji-Ae, Han, Seungwoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824762/ https://www.ncbi.nlm.nih.gov/pubmed/31626133 http://dx.doi.org/10.1097/MD.0000000000017594 |
Ejemplares similares
-
Bone morphogenetic protein receptor 2 in patients with idiopathic portal hypertension
por: De Gottardi, Andrea, et al.
Publicado: (2012) -
Bone morphogenetic proteins, genetics and the pathophysiology of primary pulmonary hypertension
por: Caestecker, Mark De, et al.
Publicado: (2001) -
Reply to “Bone morphogenetic protein's contribution to pulmonary artery hypertension”
por: King, Tyler, et al.
Publicado: (2016) -
Commentary: Bone morphogenetic protein's contribution to pulmonary artery hypertension: Should this raise concern for patients undergoing spinal fusions with bone morphogenetic protein?
por: Epstein, Nancy E.
Publicado: (2014) -
The Classic: Bone Morphogenetic Protein
por: Urist, Marshall R., et al.
Publicado: (2009)